Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity, and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity, and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

December 2020; 6 (6) Clinical/Scientific NotesOpen Access

Blended phenotype of adult-onset Alexander disease and spinocerebellar ataxia type 6

Takashi Odo, Tomoko Okamoto, Noriko Sato, Yuji Takahashi
First published October 2, 2020, DOI: https://doi.org/10.1212/NXG.0000000000000522
Takashi Odo
From the Department of Neurology (T. Odo, T. Okamoto, Y.T.), National Center Hospital, National Center of Neurology and Psychiatry; and Department of Radiology (N.S.), National Center Hospital, National Center of Neurology and Psychiatry.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoko Okamoto
From the Department of Neurology (T. Odo, T. Okamoto, Y.T.), National Center Hospital, National Center of Neurology and Psychiatry; and Department of Radiology (N.S.), National Center Hospital, National Center of Neurology and Psychiatry.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Sato
From the Department of Neurology (T. Odo, T. Okamoto, Y.T.), National Center Hospital, National Center of Neurology and Psychiatry; and Department of Radiology (N.S.), National Center Hospital, National Center of Neurology and Psychiatry.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Takahashi
From the Department of Neurology (T. Odo, T. Okamoto, Y.T.), National Center Hospital, National Center of Neurology and Psychiatry; and Department of Radiology (N.S.), National Center Hospital, National Center of Neurology and Psychiatry.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Blended phenotype of adult-onset Alexander disease and spinocerebellar ataxia type 6
Takashi Odo, Tomoko Okamoto, Noriko Sato, Yuji Takahashi
Neurol Genet Dec 2020, 6 (6) e522; DOI: 10.1212/NXG.0000000000000522

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
478

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Alexander disease is an autosomal dominant hereditary disease characterized by progressive spastic paraplegia, ataxia, and bulbar symptoms caused by mutations in the glial fibrillary acidic protein (GFAP) gene. Previous nation-wide surveillance revealed that the prevalence rate in Japan is estimated at 1 in 2.7 million people.1 Meanwhile, SCA6 is an autosomal dominant spinocerebellar ataxia characterized by adult-onset pure cerebellar ataxia. The prevalence of SCA6 is estimated to be 1 in 100,000 people in Japan.2 Here, we report an extremely rare case presenting with a blended phenotype of adult-onset Alexander disease and SCA6.

Clinical report

The patient was a 57-year-old woman presenting with progressive ataxia, facial and limb numbness, dysarthria, and dysphagia. Familial history showed that her father was genetically diagnosed with SCA6 (figure, A). At age 35 years, the patient experienced clumsiness in her right hand. At age 45 years, she developed rotation vertigo and visited our department. Her familial history suggested the diagnosis of SCA6, which was genetically confirmed. She gradually developed mild dysarthria since then, although she did not experience difficulty in verbal communication. At age 54 years, numbness appeared in both upper limbs and the lower face. At age 55 years, she developed dysphagia and noticed rapid exacerbation of dysarthria to the point that verbal communication became difficult. Neurologic examination showed cerebellar ataxia, dysarthria, dysphagia, spastic paraplegia, and sensory disturbance in all modalities in the extremities and lower face. MRI showed severe atrophy of the medulla oblongata and cervical spinal cord with preserved basal pons, which is called tadpole appearance. The anterior portion of the medulla oblongata showed high-intensity signals on T2-weighted MRI. The midbrain tegmentum and the cerebellum were also atrophic (figure, B–D). All these MR findings are characteristic of Alexander disease.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Genetic data of the proband and brain MRI of the proband and his mother

(A) Pedigree chart of the family. The proband is shown with an arrow. Those who underwent genetic tests are indicated as E+ and not as E−. Patients whose diagnosis was established as corresponding diseases are shown in black and suggestive but not established in gray. Her paternal grandfather developed a progressive gait abnormality suggestive of SCA6. Her mother was diagnosed as Alexander disease based on typical brain MRI findings, although she did not undergo genetic tests. (B–E) Brain MRIs. T2-weighted images of the proband (B) and her mother (E) and fluid-attenuated inversion recovery (FLAIR) images of the proband (C, D) showed atrophy of the midbrain, cerebellum, medulla, and upper cervical spinal cord, the latter 2 designated as tadpole appearance characteristic for Alexander disease. High-intensity signals were observed in the dentate nucleus (C) and medulla oblongata (B, D) in the proband. Cerebellar atrophy was more severe in the proband than in her mother (D, E), presumably due to concomitant SCA6. (F) Mutational analysis of the proband. The upper row: PCR fragment analysis for the triplet repeat expansion in the SCA6 locus. The lower row: an electropherogram of a GFAP mutation c.827G>T (p.R276L). An arrow shows the heterozygous mutation in GFAP. GFAP = glial fibrillary acidic protein.

Her DNA sample was obtained with IRB-approved informed consent. PCR-based fragment analysis was performed to detect triplet repeat expansions in CACNA1A. Direct nucleotide sequencing analysis was conducted for whole exons of GFAP with specific genomic primers (supplemental method e-1, links.lww.com/NXG/A326). The mutational analysis revealed both an expansion of the CAG repeat (23 repeats) in CACNA1A and a known heterozygous point mutation in the GFAP gene (c.827G>T, p.R276L) (figure, f).

Her mother had developed difficulty in walking at age 66 years and was diagnosed clinically with amyotrophic lateral sclerosis. However, her brain MRIs were also suggestive of Alexander disease (figure, e), although cerebellar atrophy was less severe than in the proband. Based on the clinical radiologic findings and genetic data, we concluded that the proband inherited Alexander disease from her mother and SCA6 from her father and presented with a blended phenotype of both diseases.

Discussion

Alexander disease is divided into 3 types based on location: type 1 is the cerebral dominant type, type 2 is the medulla oblongata/spinal cord dominant type, and type 3 is the mixed type. According to clinical symptoms and imaging findings, our patient was classified as type 2. Previous reports have shown that patients with the mutation also presented with type 2 phenotypes, predominantly bulbar and pyramidal signs with minimal cerebellar ataxia. In these individuals, brain MRI revealed typical T2-weighted high-intensity lesions in the medulla oblongata and cervical lesion and mild cerebellar atrophy.3,4 In contrast, our patient developed ataxia as the initial symptom, suggesting that concomitant SCA6 played a major role in the symptomatic onset with the subsequent rapid deterioration caused by the GFAP mutation. Whether the underlying degeneration process of SCA6 triggered the rapid deterioration caused by the GFAP mutation is an intriguing issue to be discussed. In the animal model of SCA1, activation of astrocytes with increased expression of GFAP occurred early in the absence of neuronal death. This suggests that expanded polyglutamine stretches per se are the trigger of astrocyte pathology.5 Likewise, astrocytic expanded polyglutamine affected glial glutamatergic clearing and caused neuronal dysfunction in Huntington disease model mice.6 Therefore, it is plausible to hypothesize that accumulation of expanded polyglutamine stretches and dysfunction of GFAP proteins might confer synergistic effects on the clinical course in our patient. Accumulation of similar patients or model animal experiments using double-transgenic mice would be warranted to investigate the hypothesis. Comprehensive gene analysis using next-generation sequencers has occasionally revealed pathogenic mutations of multiple mendelian inherited diseases, and the concept of blended phenotype has been proposed.7 This report describes a blended phenotype caused by an extremely rare combination of Alexander disease and SCA6. A take-home message is that in cases in which clinical course and physical examination are atypical or complicated, and multiple familial history exists, the possibility of blended phenotypes should be taken into consideration.

Study funding

No targeted funding reported.

Disclosure

The authors report no disclosures. Go to Neurology.org/NG for full disclosures.

Acknowledgment

The authors thank Shoko Watanabe, PhD, for technical assistance including mutational analysis.

Appendix Authors

Footnotes

  • Go to Neurology.org/NG for full disclosures. Funding information is provided at the end of the article.

  • The Article Processing Charge was funded by the authors.

  • Go to Neurology.org/NG for full disclosures. Funding information is provided at the end of the article.

  • Received June 1, 2020.
  • Accepted in final form August 19, 2020.
  • Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Yoshida T,
    2. Sasaki M,
    3. Yoshida M, et al
    . Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol 2011;258:1998–2008.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Tsuji S,
    2. Onodera O,
    3. Goto J,
    4. Nishizawa M
    ; Diseases OBotSGoA. Sporadic ataxias in Japan—a population-based epidemiological study. Cerebellum 2008;7:189–197.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Namekawa M,
    2. Takiyama Y,
    3. Aoki Y, et al
    . Identification of GFAP gene mutation in hereditary adult-onset Alexander's disease. Ann Neurol 2002;52:779–785.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Namekawa M,
    2. Takiyama Y,
    3. Honda J,
    4. Shimazaki H,
    5. Sakoe K,
    6. Nakano I
    . Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature. BMC Neurol 2010;10:21.
    OpenUrlPubMed
  5. 5.↵
    1. Cvetanovic M,
    2. Ingram M,
    3. Orr H,
    4. Opal P
    . Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience 2015;289:289–299.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Meunier C,
    2. Merienne N,
    3. Jollé C,
    4. Déglon N,
    5. Pellerin L
    . Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease. Glia 2016;64:1841–1856.
    OpenUrl
  7. 7.↵
    1. Yang Y,
    2. Muzny DM,
    3. Reid JG, et al
    . Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502–1511.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.ng.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Clinical report
    • Discussion
    • Study funding
    • Disclosure
    • Acknowledgment
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures

Related Articles

  • No related articles found.

Topics Discussed

  • Gait disorders/ataxia
  • MRI
  • Cerebellum
  • Spinocerebellar ataxia
  • Trinucleotide repeat diseases

Alert Me

  • Alert me when eletters are published
Advertisement
Neurology Genetics: 7 (2)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise